MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, CTKB has $494,919K in assets. $116,348K in debts. $93,281K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
516.56%
Quick Ratio
447.88%
Cash Ratio
124.03%
Debt to Asset Ratio
23.51%
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Trade accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Deferred revenue, current
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
93,281 75,470
Restricted cash
0 0
Marketable securities
168,453 186,552
Trade accounts receivable, net
56,632 56,232
Inventories
51,649 49,487
Prepaid expenses and other current assets
18,474 15,084
Total current assets
388,489 382,825
Deferred income tax assets, noncurrent
38,393 35,765
Property and equipment, net
18,046 18,352
Operating lease right-of-use assets
11,158 16,387
Goodwill
16,698 16,707
Intangible assets, net
17,676 18,601
Other noncurrent assets
4,459 4,683
Total assets
494,919 493,320
Trade accounts payable
7,632 6,853
Legal settlement liability, current
2,177 1,968
Accrued expenses
20,233 21,604
Other current liabilities
16,426 14,717
Deferred revenue, current
28,739 28,128
Total current liabilities
75,207 73,270
Legal settlement liability, noncurrent
8,158 8,477
Deferred revenue, noncurrent
16,315 16,625
Operating lease liability, noncurrent
13,494 14,119
Long term debt
655 791
Other noncurrent liabilities
2,519 2,481
Total liabilities
116,348 115,763
Common stock, 0.001 par value 1,000,000,000 authorized shares as of september 30, 2025 and december31, 2024, respectively 127,864,830 and 129,205,901 issued and outstanding shares as of september 30, 2025 and december31, 2024, respectively
128 127
Additional paid-in capital
435,284 429,652
Accumulated deficit
-57,662 -52,184
Accumulated other comprehensive gain
821 -38
Total stockholders equity
378,571 377,557
Total liabilities and stockholders equity
494,919 493,320
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$18,474K Inventories$51,649K Trade accountsreceivable, net$56,632K Marketable securities$168,453K Cash and cashequivalents$93,281K Other noncurrentassets$4,459K Intangible assets, net$17,676K Goodwill$16,698K Operating leaseright-of-use assets$11,158K Property and equipment,net$18,046K Deferred income taxassets, noncurrent$38,393K Total current assets$388,489K Total assets$494,919K Total liabilities andstockholders equity$494,919K Total stockholdersequity$378,571K Total liabilities$116,348K Accumulated deficit-$57,662K Accumulated othercomprehensive gain$821K Additional paid-in capital$435,284K Other noncurrentliabilities$2,519K Long term debt$655K Operating leaseliability, noncurrent$13,494K Deferred revenue,noncurrent$16,315K Legal settlementliability, noncurrent$8,158K Total currentliabilities$75,207K Common stock, 0.001 parvalue 1,000,000,000...$128K Deferred revenue,current$28,739K Other currentliabilities$16,426K Accrued expenses$20,233K Legal settlementliability, current$2,177K Trade accountspayable$7,632K

Cytek Biosciences, Inc. (CTKB)

Cytek Biosciences, Inc. (CTKB)